Human medicines European public assessment report (EPAR): Teriparatide Sun, teriparatide, Date of authorisation: 18/11/2022, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Teriparatide Sun, teriparatide, Date of authorisation: 18/11/2022, Revision: 4, Status: Authorised

European Medicines Agency (EMA) and European Respiratory Society (ERS) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 October 2025, 13:00 (CET) to 30 October 2025, 15:00 (CET)

European Medicines Agency (EMA) and European Respiratory Society (ERS) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 October 2025, 13:00 (CET) to 30 October 2025, 15:00 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.